Glenmede Investment Management, LP Haleon PLC Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Haleon PLC stock. As of the latest transaction made, Glenmede Investment Management, LP holds 69,864 shares of HLN stock, worth $669,995. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,864
Previous 75,629
7.62%
Holding current value
$669,995
Previous $784 Million
99.92%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HLN
# of Institutions
679Shares Held
452MCall Options Held
133KPut Options Held
0-
Dodge & Cox San Francisco, CA154MShares$1.48 Billion0.8% of portfolio
-
Clearbridge Investments, LLC New York, NY33.3MShares$320 Million0.24% of portfolio
-
Morgan Stanley New York, NY18.5MShares$178 Million0.01% of portfolio
-
Harding Loevner LP Bridgewater, NJ17.9MShares$172 Million1.22% of portfolio
-
Wellington Management Group LLP Boston, MA15.7MShares$150 Million0.03% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $44.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...